Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Brain+ invites investors and other stakeholders to a webinar for a presentation of its Half Year 2025 report

Brain+

NEWS RELEASE

Copenhagen, Denmark, 1 September 2025 – Brain+ A/S (Nasdaq First North: BRAINP)

Brain+ A/S (“Brain+” or the “Company”) will host a live webinar on Thursday, 4 September 2025 at 15:30 CEST / 14:30 BST to present the Company’s report for the Half Year 2025. The report was published on Thursday, 28 August 2025. To register for the webinar and post questions to management in advance, click here.

Participants from Brain+ will be CEO Devika Wood, SVP for Partnerships Fiona Costello and CFO Hanne Vissing Leth, who will present highlights of the report and provide details on commercial activities as well as on sales and financial outlook.

Brain+’ published its report for the Half Year 2025 on Thursday 28 August 2025 after market close. To present the report and provide further details on the status and outlook for the business with special focus on commercial activities, sales expectations and financial outlook, the Company invites its shareholders, other investors and stakeholders to a webinar.

Event Details

  • Title: Presentation of Half Year 2025 report: Focus on commercial activities and sales outlook
  • Date: Thursday, 4 September 2025
  • Time: 15:30 – 16:30 CEST / 14:30 – 15:30 BST
  • Location: Online (Stokk.io)
  • To register and ask questions in advance: Click here
  • Participants from Brain+: CEO Devika Wood; SVP, Partnerships Fiona Costello and CFO Hanne Vissing Leth.

---

About Brain+

Brain+ A/S is a digital health company listed on Nasdaq First North Growth Market Denmark, building the world’s first scalable dementia care platform. Its flagship product, Ayla - your CST Assistant, is a solution designed to support the consistent delivery of high-quality Cognitive Stimulation Therapy (CST), a non-pharmacological, NICE-recommended intervention for people with mild to moderate dementia.

 

Contact Information

Devika Wood, CEO: + 44 7429 280366, devika@brain-plus.com

Hanne Vissing Leth, CFO: +45 53 88 99 02, hanne@brain-plus.com

Brain+ vision: Building the world’s first scalable dementia care platform to help people affected by dementia, live better lives.


Attachments
2025-0901 B News Release_Invitation to H1 2025 webinar.pdf
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.